Clinical Trial Update: Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the diagnostic validity of [18F]FSPG PET for detecting acute rejection after heart or liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Rejection
• Heart Transplantation
• Liver Transplantation

Drugs mentioned

• 18F-FSPG

Snippet

Sponsor: Asan Medical Center | Conditions: Graft Rejection, Heart Transplantation | Phase 2 | Status: COMPLETED